Biology of BMP signalling and cancer

Clinical and Translational Oncology

Volumn 11, Issue 3, 2009, Pages 126-137

  Blanco Calvo, Moisés ^a   Bolós Fernández, Victoria ^b   Medina Villaamil, Vanessa ^a   Aparicio Gallego, Guadalupe ^a   Díaz Prado, Silvia ^a   Grande Pulido, Enrique ^b  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b PFIZER INC   (United States)

Author keywords

BMP pathway; Cancer; Signalling

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CHORDIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NOGGIN; OSTEOGENIC PROTEIN 1; OSTEOGENIN; SMAD PROTEIN; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUMO PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE NEDD4; WNT PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; GLYCOPROTEIN; SIGNAL PEPTIDE;

BINDING AFFINITY; BINDING SITE; BONE METASTASIS; BONE REGENERATION; BRANCHING MORPHOGENESIS; BREAST CANCER; CANCER STEM CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELL RENEWAL; CHONDROGENESIS; CYTOPLASM; EMBRYO DEVELOPMENT; HAIR GROWTH; HUMAN; INTRACELLULAR TRANSPORT; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OSSIFICATION; POSTNATAL DEVELOPMENT; PROSTATE CANCER; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; BONE TUMOR; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; METASTASIS; PHYSIOLOGY; STEM CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; BONE NEOPLASMS; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; SMAD PROTEINS; STEM CELLS;

EID: 65649097303     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/S12094-009-0328-8     Document Type: Review

References (27)

1. Canalis E, Economides AN, Gazzerro E (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235
2. Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651-657
3. Lin SJ, Lerch TF, Cook RW et al (2006) The structural basis of TGF-protein, and activin ligand binding. Reproduction 132:179-190
4. Shi Y, Massagué J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700
5. Xiao YT, Xiang LX, Shao JZ (2007) Bone morphogenetic protein. Biochem Biophys Res Commun 362:550-553
6. Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51-65
7. Kochanowska I, Chaberek S, Wojtowicz A et al (2007) Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton. BMC Musculoskelet Disord 8:128-137
8. Varga AC, Wrana JL (2005) The disparate role of BMP in stem cell biology. Oncogene 24:5713-5721
9. Balemans W, Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev Biol 250:231-250
10. Mazerbourg S, Sangkuhl K, Luo CW et al (2005) Identification of receptors and signaling pathways for orphan bone morphogenetic protein/ growth differentiation factor ligands based on genomic analyses. J Biol Chem 280:32122-32132
11. Kirkbride KC, Townsend TA, Bruinsma MW et al (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283:7628-7637
12. David L, Mallet C, Mazerbourg S et al (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptorlike kinase 1 (ALK1) in endothelial cells. Blood 109:1953-1961
13. Shi W, Chang C, Nie S et al (2007) Endofin acts as a Smad anchor for receptor activation in BMP signaling. J Cell Sci 120:1216-1224
14. Ross S, Hill CS (2008) How the Smads regulate transcription. Int J Biochem Cell Biol 40:383-408
15. Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783-2810
16. Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56-61
17. Hogan BL (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432-438
18. Lamm ML, Podlasek CA, Barnett DH et al (2001) Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol 232:301-314
19. Grishina IB, Kim SY, Ferrara C et al (2005) BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol 288:334-347
20. Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG (2007) Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 22:1129-1147
21. Dai J, Kitagawa Y, Zhang J et al (2004) Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res 64:994-999
22. Davies SR, Watkins G, Douglas-Jones A et al (2007) Bone morphogenic proteins 1 to 7 in human breast carcinoma. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings 25[18S], Abstract 21154
23. Kodach LL, Wiercinska E, de Miranda NF et al (2008) The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134:1332-1341
24. Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184-187
25. Haramis AP, Begthel H, van den Born M et al (2004) De novo crypt formation and juvenile polyposis on BMP Inhibition in mouse intestine. Science 303:1684-1686
26. Boulay JL, Mild G, Lowy A et al (2002) SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 87:630-634
27. Hardwick JC, Van Den Brink GR, Bleuming SA et al (2004) Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126:111-121